Helena M. Santos
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?
Journal: Seminars in arthritis and rheumatism
Published: March 15, 2025
Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis - data from a Portuguese registry.
Journal: Rheumatology (Oxford, England)
Published: January 08, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.
Journal: The Journal of rheumatology
Published: January 02, 2025
Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE.
Journal: bioRxiv : the preprint server for biology
Published: September 30, 2024
Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE.
Journal: Nature communications
Published: August 23, 2024
Lipidome plasticity in medium- and long-chain fatty acid oxidation disorders: Insights from dried blood spot lipidomics.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: August 01, 2024
Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt.
Journal: Scientific reports
Published: April 01, 2024
Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors.
Journal: Biomolecules
Published: February 08, 2024
Last Updated: 09/26/2026